BioPharma
31 January, 2025 | Friday | News
China Approves Sarclisa as First Anti-CD38 Therapy for Newly Diagnosed Multiple Myeloma Patients
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase ...
Lab
28 January, 2025 | Tuesday | News
ThinkCyte Expands Product Line to Advance Drug Discovery and Disease Research Innovation
ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysi...
BioTech
06 February, 2025 | Thursday | News
Thermo Fisher Scientific Launches CorEvitas Adolescent Alopecia Areata Registry to Advance Real-World Research
Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need for real-world,...
Contract Services
05 February, 2025 | Wednesday | News
Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production
3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor H (CPV-104) program, which is expected to enter a firs...
Consumer Health
05 February, 2025 | Wednesday | News
Genentech Secures FDA Approval for Susvimo the First Long-Lasting Treatment for Diabetic Macular Edema
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) – – With as few as two treatments per ye...
White Paper
07 January, 2025 | Tuesday | News
2025 Pharma and Medical Device Trends for Manufacturing Leaders
Product Spot Light
28 January, 2025 | Tuesday | News
ThinkCyte Expands Product Line to Advance Drug Discovery and Disease Research Innovation
Premium Article
03 February, 2025 | Monday | Product Spotlight
Say goodbye to the cable tie and hello to the BioTitan Retention Device—zero leaks reported!
Bio Invest
03 February, 2025 | Monday | News
GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply
Biopharma APAC Infomercial
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
